Browse > Article
http://dx.doi.org/10.24304/kjcp.2019.29.3.156

A Study of Irritable Bowel Syndrome and Stress on Female College Students in Korea  

Shin, Jieun (Graduate School of Clinical Pharmacy, Sookmyung Women's University)
Kim, Kwang Joon (College of Pharmacy, Woosuk University)
Bang, Joon Seok (College of Pharmacy, Sookmyung Women's University)
Publication Information
Korean Journal of Clinical Pharmacy / v.29, no.3, 2019 , pp. 156-165 More about this Journal
Abstract
Objective: The purpose of this study was to provide a database for making better decisions of the treatment of the irritable bowel syndrome (IBS) patient, and for improving the recognition of IBS in the Korean society. Methods: The survey was conducted on 174 female college students in Korea from January 2017 to January 2018. Out of the total students surveyed, 160 questionnaires were analyzed after excluding 14 uncompleted questionnaires. Results: Based on the survey, the prevalence of IBS among female college students in Korea was found to be 13.8%. Statistically, the results proved that there were significant differences in the stress levels between the students with IBS and non-IBS diagnosed by ROME IV criteria. Students with IBS had higher stress levels than students without the ailment. Conclusions: Based on this study, stress management related treatment should be actively considered. Furthermore, it is necessary to develop more efficient and updated guidelines for the treatment of IBS and new patient care programs.
Keywords
Irritable Bowel Syndrome; stress; cause; treatment; female college students; ROME IV;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
연도 인용수 순위
1 Kim HJ, Cha RR, Kim HJ. Understanding of ROME IV criteria: Irritable bowel syndrome and functional diarrhea. Korean J Med 2017;92(4):366-71.   DOI
2 Kasper D, Fauci A, Hauser S, et al. In; Harrison's Principles of Internal Medicine 19e (Vol. 1 & Vol. 2). McGraw-Hill Education. 2015:269-84.
3 Kwan AC, Bao TN, Chakkaphak S, et al. Validation of Rome II criteria for functional gastrointestinal disorders by factor analysis of symptoms in Asian patient sample. J Gastroenterol Hepatol 2003;18(7):796-802.   DOI
4 Ford AC, Brandt LJ, Young C, et al. Efficacy of 5-$HT_3$ antagonists and 5-$HT_4$ agonists in irritable bowel syndrome: systematic review and meta-analysis. Am J Gastroenterol 2009;104:1831-43.   DOI
5 Matsueda K, Harasawa S, Hongo M, et al. A phase II trial of the novel serotonin type 3 receptor antagonist ramosetron in Japanese male and female patients with diarrheapredominant irritable bowel syndrome. Digestion 2008;77:225-35.   DOI
6 Matsueda K, Harasawa S, Hongo M, et al. A randomized, double-blind, placebo-controlled clinical trial of the effectiveness of the novel serotonin type 3 receptor antagonist ramosetron in both male and female Japanese patients with diarrhea-predominant irritable bowel syndrome. Scand J Gastroenterol 2008;43:1202-11.   DOI
7 Mayer EA, Naliboff BD, Chang L, et al. Stress and irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol 2001;280(4):G519-24.   DOI
8 Manning AP, Thompson WG, Heaton KW, et al. Towards positive diagnosis of the irritable bowel. Br Med J 1978;2:653-4.   DOI
9 Drossman DA, Hasler WL. Rome IV-functional GI disorders: disorders of gut-brain interaction. Gastroenterology 2016;150:1257-61.   DOI
10 PanelNow Solution. Available from https://m.blog.naver.com/PostView.nhn?blogId=panelnow&logNo=221019985620&proxyReferer=http%3A%2F%2Fwww.google.com%2Furl%3Fsa%3Dt%26rct%3Dj%26q%3D%26esrc%3Ds%26source%3Dweb%26cd%3D6%26ved%3D2ahUKEwiopYj8prrhAhVPyYsBHV0AD6sQFjAFegQIABAB%26url%3Dhttp%253A%252F%252Fm.blog.naver.com%252Fpanelnow%252F221019985620%26usg%3DAOvVaw0kI4k0aAam4f4cpKJXQnQ0. Accessed November 15, 2017.
11 Yim JH, Bae JM, Choi SS, et al. The validity of modified Koreantranslated BEPSI (Brief Encounter Psychosocial Instrument) as instrument of stress measurement in outpatient clinic. J Korean Acad Fam Med 1996;17:42-53.
12 Park HJ. Treatment guidelines of irritable bowel syndrome. Korean J Neurogastroenterol Motil 2005;11:36-43.
13 Park JH, Byeon JS, Shin WG, et al. Diagnosis of irritable bowel syndrome: a systematic review. Korean J Gastroenterol 2010;55:308-15.   DOI
14 Kwon JG, Park KS, Park JH, et al. Guidelines for the Treatment of Irritable Bowel Syndrome. Korean J Gastroenterol 2011;57(2):82-99.   DOI
15 Jung D, Park H, Kim M. A study of irritable bowel syndrome, self-esteem, depression, and physical health in female university students. Korean J Women Health Nurs 2008;14(4):306-13.   DOI
16 Blanchard EB, Keefer L, Galovski TE, et al. Gender differences in psychological distress among patients with irritable bowel syndrome. J Psychosom Res 2001;50(5):271-5.   DOI
17 Lee KE. Health Care Resource Use and Patients' Satisfaction for Irritable Bowel Syndrome. Ewha Womans University Graduate School, Master's Thesis, 2015.
18 Shiotani A, Miyanishi T, Takahashi T. Sex differences in irritable bowel syndrome in Japanese university students. J Gastroenterol 2006;41(6):562-8.   DOI
19 Chang L. The role of stress on physiologic responses and clinical symptoms in irritable bowel syndrome. Gastroenterology 2011;140(3):761-5.   DOI
20 Lee S, Suh M. Exploring Subjective Stress, Sleep and Diurnal Variation of Salivary Cortisol in Korean Female Adults. J Korean Biol Nurs Sci 2016;18(1):9-16.   DOI
21 Han JU, Cho A, Choe YK, et al. The prevalence of Irritable Bowel Syndrome-type symptoms and the relationship with stress in medical, dental, and nursing students. Korean J Health Promot Dis Pre 2005;5(1):1-6.
22 Locke III GR, Zinsmeister AR, Talley NJ, et al. Risk factors for irritable bowel syndrome: role of analgesics and food sensitivities. Am J Gastroenterol 2000;95(1):157-65.   DOI
23 Kim MJ. A study of IBS and sleep quality of student majoring in dental hygienist in some areas. J Dent Hyg 2014;14(1):22-8.
24 Choi MK, Chung HK, Chang BH, et al. Estimation of disease burden of irritable bowel syndrome. Korea Institute of Health and Welfare Research Report 2011;1-208.
25 Brandt LJ, Chey WD, Foxx-Orenstein AE, et al. American College of Gastroenterology Task Force on Irritable Bowel Syndrome. An evidence-based position statement on the management of irritable bowel syndrome. Am J Gastroenterol 2009;104(Suppl 1):S1-S35.
26 El-Serag HB, Olden K, Bjorkman D. Health-related quality of life among persons with irritable bowel syndrome: a systematic review. Aliment Pharmacol Ther 2002;16:1171-85.   DOI